ANDA 213695, held by Jubilant Generics. Oseltamivir Phosphate.
As of Nov 16, 2026, ANDA 213695 (Oseltamivir Phosphate), held by Jubilant Generics, was first approved by FDA on Mar 3, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 3, 2025 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Oseltamivir PhosphateEQ 6MG BASE/ML ยท for suspension;oral | Oseltamivir Phosphate | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters